Correlation Between Indaptus Therapeutics and Biogen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Biogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Biogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Biogen Inc, you can compare the effects of market volatilities on Indaptus Therapeutics and Biogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Biogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Biogen.

Diversification Opportunities for Indaptus Therapeutics and Biogen

  Correlation Coefficient

Good diversification

The 3 months correlation between Indaptus and Biogen is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Biogen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biogen Inc and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Biogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biogen Inc has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Biogen go up and down completely randomly.

Pair Corralation between Indaptus Therapeutics and Biogen

Given the investment horizon of 90 days Indaptus Therapeutics is expected to under-perform the Biogen. In addition to that, Indaptus Therapeutics is 4.27 times more volatile than Biogen Inc. It trades about 0.0 of its total potential returns per unit of risk. Biogen Inc is currently generating about 0.09 per unit of volatility. If you would invest  21,806  in Biogen Inc on March 24, 2024 and sell it today you would earn a total of  594.00  from holding Biogen Inc or generate 2.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Indaptus Therapeutics  vs.  Biogen Inc

Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Indaptus Therapeutics is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.
Biogen Inc 

Risk-Adjusted Performance

3 of 100

Compared to the overall equity markets, risk-adjusted returns on investments in Biogen Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong forward indicators, Biogen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Indaptus Therapeutics and Biogen Volatility Contrast

   Predicted Return Density   

Pair Trading with Indaptus Therapeutics and Biogen

The main advantage of trading using opposite Indaptus Therapeutics and Biogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Biogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biogen will offset losses from the drop in Biogen's long position.
The idea behind Indaptus Therapeutics and Biogen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings